Also, Fraune et al. (2019) [11] reported their results of 3.5% (7/200) dMMR/MSI advanced PCa patients by IHC in a tissue microarray (TMA) format with a confirmation of the suspicion of dMMR by Bethesda PCR panel with BAT-25, BAT-26, D2S123, D5S346, and D17S250 markers. The gene discussed is BAAT; the disease is posterior cortical atrophy.